Inhibitor of angiotensin II type I receptors Eprosartan and Antiodarone as a combined treatment of advanced heart failure and atrial fibrillation

被引：3
|
作者：
Grigoryan, S.
Stepanyan, A. A.
Hazarapetyan, L. G.
机构：
[1] Inst Cardiol, Dept Arrhythmia, Yerevan, Armenia
[2] Cardiol Clin, Gjumri, Armenia
[3] NIH, Yerevan, Armenia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2007年 / 6卷
关键词：
D O I：
10.1016/S1567-4215(07)60421-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [41] Mitogen-activated protein kinases mediate upregulation of hypothalamic angiotensin II type 1 receptors in heart failure rats
    Wei, Shun-Guang
    Yu, Yang
    Zhang, Zhi-Hua
    Weiss, Robert M.
    Felder, Robert B.
    HYPERTENSION, 2008, 52 (04) : 679 - 686
  • [42] The role of angiotensin (ANG) II type 1 receptors in the nerve-mediated volume retention of rats with congestive heart failure
    Roland, V
    JOURNAL OF HYPERTENSION, 2000, 18 : S231 - S231
  • [43] Exercise training and renal denervation attenuate the expression of angiotensin II Type 1 and 2 receptors in rabbits with chronic heart failure
    Clayton, Sarah C.
    Curry, Pamela L.
    Li, Yu
    Zucker, Irving H.
    FASEB JOURNAL, 2008, 22
  • [44] Brain Angiotensin II Type 1 Receptors in Astrocytes, not Neurons, Are Upregulated in Mice With Myocardial Infarction-Induced Heart Failure
    Isegawa, Kengo
    Hirooka, Yoshitaka
    Kishi, Takuya
    Sunagawa, Kenji
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S142 - S142
  • [45] Ventricular-specific expression of angiotensin II type 2 receptors causes dilated cardiomyopathy and heart failure in transgenic mice
    Yan, XH
    Price, RL
    Nakayama, M
    Ito, K
    Schuldt, AJT
    Manning, WJ
    Sanbe, A
    Borg, TK
    Robbins, J
    Lorell, BH
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (05): : H2179 - H2187
  • [46] Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure
    Davie, AP
    Rumley, A
    Lowe, GDO
    McMurray, JJV
    THROMBOSIS AND HAEMOSTASIS, 2001, 86 (06) : 1585 - 1586
  • [47] Prophylactic antifibrotic effect of combined therapy with pentoxyphyllin, angiotensin I type I receptor blocker and cycloxygenase II inhibitor on experimental fibrogenesis in rats
    Abbass, S. M.
    El-Ashry, E. L.
    El-Fiky, B. K.
    El-Shennawy, S.
    El-Defrawy, N. M.
    Badr, M. T.
    LIVER INTERNATIONAL, 2006, 26 : 44 - 44
  • [48] ACE inhibitor and angiotensin II type 1 receptor blocker differently regulate ventricular fibrosis in hypertensive diastolic heart failure
    Yamamoto, K
    Mano, T
    Yoshida, J
    Sakata, Y
    Nishikawa, N
    Nishio, M
    Ohtani, T
    Hori, M
    Miwa, T
    Masuyama, T
    JOURNAL OF HYPERTENSION, 2005, 23 (02) : 393 - 400
  • [49] Melatonin inhibits angiotensin II-induced atrial fibrillation through preventing degradation of Ang II Type I Receptor-Associated Protein (ATRAP)
    Xie, Xin
    Shen, Ting -ting
    Bi, Hai-lian
    Su, Zhuo-lin
    Liao, Zi-qi
    Zhang, Ying
    Shi, Lei
    Xia, Yun-long
    BIOCHEMICAL PHARMACOLOGY, 2022, 202
  • [50] Treatment with the angiotensin II type 1 receptor antagonist candesartan does not reduce recurrence rate of atrial fibrillation after electrical cardioversion
    Tveit, A.
    Grundvold, I.
    Seljeflot, I.
    Abdelnoor, M.
    Arnesen, H.
    Smith, P.
    EUROPEAN HEART JOURNAL, 2006, 27 : 46 - 46
12345